Short Communication
Melatonin as an Anti-cancer Agent: Time of Administration May Be Critical
Published: January, 2024
ISSN: 2688-8203
Managing Editor: Julia Vinscent
Contact us at:
Advances in Cancer Research & Clinical Imaging (ACRCI) is a double blind peer review journal which publishes research papers with novel concepts, new methods, new regimens and new therapeutic agents that approaches in cancer & oncology research. ACRCI provides scope to the topics like early Diagnosis, Screening, Symptoms, Diagnostics and Staging, Chemotherapy, Preclinical and Clinical Cancer Therapeutics, Leukemia, Oncology, Carcinogenesis, Melanoma, Sarcoma, Tumor, Metastasis and all types of cancers and their treatment methods, precautions, etc. We keep effort to understand etiology of cancer and control cancer to readers and bring awareness in them. It is a monthly published journal which accepts all types of articles like Editorial, Research, Review, Case Report, Short Communication, Perspectives, Mini Review, Clinical Image, Letter to Editor, e-Books, Video articles etc.
Short Communication
Melatonin as an Anti-cancer Agent: Time of Administration May Be Critical
Published: January, 2024
Short Communication
Melatonin as an Anti-cancer Agent: Time of Administration May Be Critical
Published: January, 2024
Editorial
Published: December, 2023
Research Article
Published: August, 2023
Editorial
Published: July, 2023
Case Report
Secondary Budd-Chiari Syndrome due to Sarcomatous Renal Cell Carcinoma: Case Report
Published: June, 2023
Mini Review
Published: May, 2023